S&P 500 Consumer Staples Sector SEC Filings — May 21, 2026

USA S&P 500 Consumer Staples

By Gunpowder Editorial ·

19 high priority 31 medium priority 50 total filings analysed

Executive Summary

The 50 filings from the S&P 500 Consumer Staples sector reveal a sector bifurcating between scale-driven leaders and challenged players. Walmart's strong Q1 FY27 (revenue +7.3% YoY, eCommerce +26%) contrasts with a sharp negative free cash flow swing (-$2.4B YoY), signaling aggressive investment.

A major portfolio restructuring is underway as Kontoor Brands sells its Lee® business for up to $1B to focus on higher-growth brands, a move that will likely reshape the apparel landscape. Capital allocation is a key theme, with Kraft Heinz aggressively managing its balance sheet via a $1.1B debt tender, while Constellation Brands bolsters its board with top marketing talent from McDonald's. Insider activity is limited in this batch, but the Gabelli Dividend & Income Trust's proxy fight with Saba Capital Management highlights a broader activist push in closed-end funds, with performance data showing GDV up 29% in the last twelve months. Overall, the sector shows strong top-line growth for dominant players, but margin pressures from fuel costs and investment cycles are evident, creating a 'winners-take-most' dynamic.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K · 13F · 10-Q · DEFA14A · 425 · DEF 14A · S-1 · DEFM14A · 10-K

Tracking the trend? Catch up on the prior S&P 500 Consumer Staples Sector SEC Filings digest from May 20, 2026.

Investment Signals (12)

  • Walmart (WMT)

    Revenue grew 7.3% YoY (5.9% cc), eCommerce surged 26%, and advertising business grew 37%. However, free cash flow swung to -$1.9B (down $2.4B YoY). Q2 guidance for adjusted op income +7-10% cc is bullish, but the cash burn is a watch item. [BULLISH/BEARISH]

  • Kontoor Brands (KTB) (BULLISH)

    Selling Lee® for up to $1B (initial $750M + $250M earnout) to focus on higher-growth Wrangler® and Helly Hansen®. Proceeds to be deployed for share repurchases and debt paydown. This is a transformative, value-unlocking event.

  • Kraft Heinz (KHC) (BULLISH)

    Launched a $1.1B debt tender for high-coupon notes (4.375% and 4.875%), with $2.57B tendered (oversubscribed). This proactive liability management reduces future interest expense and strengthens the balance sheet.

  • Constellation Brands (STZ) (BULLISH)

    Appointed Morgan Flatley (Global CMO of McDonald's) to the board. Her deep brand-building experience from McDonald's and PepsiCo supports the company's #1 high-end beer position. No financial data, but a strong strategic hire.

  • Kontoor Brands (KTB) (BEARISH)

    The $250M earnout from the Lee® sale introduces execution risk. If performance targets are not met, total proceeds could be significantly lower, impacting the planned capital return.

  • Walmart (WMT) (BEARISH)

    Operating income negatively affected by 250 bps from higher fuel costs. While top-line growth is strong, input cost inflation is a persistent margin headwind.

  • Fund is up 29% in the last twelve months and has an 8.8% annualized return since inception. With a 6.2% distribution yield and a proxy fight against activist Saba Capital, the current setup favors management.

  • Glass Lewis recommended FOR the board's nominees, citing the fund's 'functionally best-in-class' discount (~2.8%) and outperformance of its peer group by 36% since 2023. This is a strong endorsement against activist Saba.

  • Relay Therapeutics (RLAY) (MIXED)

    Completed a $296.8M public offering at $12.00/share, with underwriters fully exercising their option. This provides a significant cash runway for clinical development, but is dilutive to existing shareholders.

  • Black Diamond Therapeutics (BDTX) (BULLISH)

    Positive Phase 2 data for silevertinib in NSCLC: 60% ORR, 91% DCR, and median PFS of 15.2 months. No new safety signals. This is a major catalyst that could lead to a pivotal trial and partnership interest.

  • Kontoor Brands (KTB) (BEARISH)

    The sale of Lee® is subject to regulatory approvals and customary closing conditions, expected in H2 2026. Any delay or failure to close would be a significant negative catalyst.

  • Thermon Group Holdings (THR) (MIXED)

    Sales grew 8% YoY to $536.3M with gross margin expansion to 45.3%, but net income fell 17% to $44.6M due to a 22% surge in SG&A and a higher tax rate. Adjusted EPS grew 15%, but free cash flow dropped 38% to $32.9M.

Risk Flags (10)

  • Walmart (WMT) / Cash Flow Risk [HIGH RISK]

    Free cash flow turned sharply negative at -$1.9B, down $2.4B YoY. Operating cash flow also decreased $0.7B to $4.7B. This level of cash burn is unsustainable and could signal aggressive inventory build or capex overruns.

  • Kontoor Brands (KTB) / Execution Risk [MEDIUM RISK]

    The $250M earnout from the Lee® sale is contingent on future performance. If the business underperforms, the total consideration drops to $750M, reducing the expected capital return to shareholders.

  • Teladoc Health (TDOC) / Governance Risk [MEDIUM RISK]

    Director David B. Snow, Jr. received significant opposition with 12.9 million votes against (16% of votes cast). This level of dissent signals shareholder dissatisfaction with board oversight or strategy.

  • TPG RE Finance Trust (TRTX) / Governance Risk [HIGH RISK]

    Director Edward 'Ted' Goldthorpe received more votes withheld (21M) than votes for (20.7M), a clear vote of no confidence from shareholders. This is a strong red flag for board effectiveness.

  • Universal Electronics (UEIC) / Shareholder Dissent [MEDIUM RISK]

    The non-binding advisory vote on executive compensation received only 5.57M votes for versus 2.28M against, a 29% opposition rate. This indicates significant shareholder discontent with pay practices.

  • Barnwell Industries (BRN) / Cash Burn Risk [HIGH RISK]

    Cash used in operating activities from continuing operations increased 184% to $2.422M in H1 FY2026 from $0.854M in H1 FY2025. The company is burning cash faster despite raising $3.365M from share issuance.

  • Brainstorm Cell Therapeutics (BCLI) / Dilution Risk [HIGH RISK]

    Filed an S-1 for a proposed public offering by selling stockholders. The company reported a flat net loss of $22.6M for two consecutive years and needs additional capital. Further dilution is imminent.

  • Kohl's (KSS) / Compensation Risk [MEDIUM RISK]

    The amended 2024 Long-Term Compensation Plan increased authorized shares by 5.2M. While passed, the potential for dilution and the company's ongoing sales struggles make this a risk for long-term shareholders.

  • ClearSign Technologies (CLIR) / Cash Runway Risk [HIGH RISK]

    Reported $7.7M in cash as of March 31, 2026, with no revenue or net income disclosed. The company is pre-revenue and burning cash, relying on small orders (flare, burner) that may not be sufficient to fund operations.

  • Pelthos Therapeutics (PTHS) / Auditor Change [MEDIUM RISK]

    Dismissed auditor CBIZ and engaged Grant Thornton. While no disagreements were reported, a change in auditor, especially after the acquisition of the prior firm, can be a red flag for financial reporting quality.

Opportunities (10)

  • Kontoor Brands (KTB) / Post-Sale Value Unlock (OPPORTUNITY)

    After selling Lee® for up to $1B, Kontoor will be a pure-play on Wrangler® and Helly Hansen®. With proceeds earmarked for share buybacks, the stock could see significant EPS accretion. Trading at a discount to sum-of-parts.

  • Black Diamond Therapeutics (BDTX) / Phase 2 Data Catalyst (OPPORTUNITY)

    The 60% ORR and 15.2-month median PFS in frontline NSCLC are best-in-class for EGFR non-classical mutations. With no new safety signals, this could attract a partnership or accelerate development, driving significant upside.

  • Relay Therapeutics (RLAY) / Strong Cash Position (OPPORTUNITY)

    The $296.8M offering provides a multi-year cash runway, de-risking the pipeline. The stock is trading near the offering price of $12.00, offering a potential entry point for investors who believe in the platform's long-term value.

  • With a 29% one-year return, an 8.8% annualized return since inception, and a 6.2% yield, GDV is a strong performer. The proxy fight with Saba creates a potential buying opportunity if the stock dips on uncertainty, with a clear catalyst in the June 29 meeting.

  • Glass Lewis highlighted ECAT's discount (~2.8%) as 'functionally best-in-class'. With the fund outperforming peers by 36% since 2023, the current discount offers a compelling entry point for income-focused investors.

  • Walmart (WMT) / eCommerce & Advertising Growth (OPPORTUNITY)

    eCommerce grew 26% globally and advertising grew 37%. These high-margin, high-growth segments are transforming Walmart's business model. The current pullback on cash flow concerns may be a buying opportunity for long-term investors.

  • Kraft Heinz (KHC) / Balance Sheet Improvement (OPPORTUNITY)

    The oversubscribed $1.1B debt tender will reduce high-cost debt, improving interest coverage and net income. This is a credit-positive event that could lead to a credit rating upgrade and lower future borrowing costs.

  • Thermon Group Holdings (THR) / Margin Expansion Story (OPPORTUNITY)

    Gross margins expanded to 45.3% (up from prior year), and adjusted diluted EPS grew 15%. If the company can control SG&A growth, there is significant operating leverage to be captured.

  • Generated a 2.5% YTD total return (Class I), outperforming leveraged loans by 180bps. With 100% first lien senior secured debt and low non-accruals (0.2%), it offers a defensive high-yield opportunity in a volatile market.

  • Ford Motor (F) / Strategic Battery Play (OPPORTUNITY)

    The DOE loan agreement and acquisition of two battery facilities in Kentucky from the BlueOval SK JV positions Ford to control its battery supply chain. This is a long-term strategic move that could lower EV production costs.

Sector Themes (6)

  • Scale-Driven Growth vs. Cash Flow Strain

    Walmart's 7.3% revenue growth and 26% eCommerce surge demonstrate the power of scale. However, the -$1.9B free cash flow highlights the massive investment required to sustain this growth, a theme likely echoed across large-cap staples. Investors must differentiate between growth and value-destructive growth.

  • Portfolio Restructuring for Focus

    Kontoor Brands' sale of Lee® for up to $1B is a prime example of a company streamlining its portfolio to focus on higher-growth assets. This trend of divesting lagging brands to unlock value and reduce complexity is likely to continue across the consumer staples sector.

  • Activist Pressure in Closed-End Funds

    The proxy fights at Gabelli Dividend & Income Trust and BlackRock ESG Capital Allocation Term Trust, both involving Saba Capital, highlight a growing activist trend in the CEF space. Funds with persistent discounts are vulnerable, creating both risk and opportunity for shareholders.

  • Proactive Balance Sheet Management

    Kraft Heinz's oversubscribed $1.1B debt tender shows a clear trend of companies using strong cash flows to de-lever and reduce interest costs. This is a credit-positive theme that supports higher valuations for investment-grade staples.

  • Input Cost Inflation as a Margin Headwind

    Walmart explicitly cited a 250 bps negative impact from higher fuel costs on operating income. This is a sector-wide headwind, and companies with less pricing power than Walmart will face more significant margin compression.

  • Biotech Innovation in Oncology

    Black Diamond Therapeutics' positive Phase 2 data and Relay Therapeutics' successful capital raise underscore a vibrant biotech sub-sector within the broader consumer staples-adjacent health space. Precision oncology remains a high-growth, high-reward area.

Watch List (8)

  • Kontoor Brands (KTB) / Lee® Sale Closing
    👁

    Watch for regulatory approvals and the final closing of the Lee® sale in H2 2026. Any delays or changes in terms will be a major catalyst. Also watch for the pace of share repurchases post-close.

  • Walmart (WMT) / Q2 FY27 Earnings
    👁

    Watch for the Q2 FY27 report (expected mid-August 2026) to see if free cash flow improves and if eCommerce growth continues at a 26%+ clip. Guidance for the back half of the year will be critical.

  • The annual meeting is scheduled for June 29, 2026. The outcome of the proxy fight with Saba Capital will determine board control and the fund's future strategy.

  • The annual meeting is on June 9, 2026. The vote will determine whether the board's nominees or Saba's slate prevails, impacting the fund's discount and distribution policy.

  • Black Diamond Therapeutics (BDTX) / Regulatory Updates
    👁

    Watch for updates on the silevertinib Phase 2 data, including potential Breakthrough Therapy designation from the FDA or plans for a pivotal trial. Partnership announcements would be a major catalyst.

  • Kraft Heinz (KHC) / Debt Tender Settlement
    👁

    The early settlement is expected on May 26, 2026. Watch for the final results and the impact on the balance sheet and interest expense for the next quarter.

  • Relay Therapeutics (RLAY) / Pipeline Milestones
    👁

    With a strong cash position, watch for upcoming clinical data readouts and pipeline updates. The company's ability to execute on its development plans will be key to stock performance.

  • Barnwell Industries (BRN) / Annual Meeting
    👁

    The annual meeting is on June 29, 2026. Watch for shareholder votes on the equity incentive plan amendment and executive compensation, which could signal confidence or dissent.

Filing Analyses (50)
Wellgistics Health, Inc. 8-K mixed materiality 8/10

21-05-2026

Wellgistics Health, Inc. announced a 1-for-50 reverse stock split approved by the board and stockholders to regain compliance with Nasdaq's minimum bid price requirement. The split will take effect on May 26, 2026, reducing outstanding shares from ~125.7 million to ~2.5 million. While the reverse split is intended to boost the stock price above the $1.00 threshold, it does not change the company's fundamental business performance or market capitalization.

  • · The reverse split was approved by stockholders on April 2, 2026.
  • · No fractional shares will be issued; any fractional share will be rounded up to the nearest whole share.
  • · Proportional adjustments will be made to stock options, warrants, convertible securities, and stock incentive plans.
  • · The total authorized number of shares will not be reduced.
  • · The company's platform connects more than 6,500 pharmacies and 200+ manufacturers.
  • · The company's forward-looking statements mention a potential acquisition of WellCare Today, LLC and integration of HealthAssist wearable technologies.
UNIVERSAL ELECTRONICS INC 8-K mixed materiality 6/10

21-05-2026

Universal Electronics Inc. held its annual meeting on May 19, 2026, where shareholders approved the declassification of the Board of Directors (effective 2027), an amendment to the 2018 Equity and Incentive Compensation Plan (adding 375,000 shares), and ratified Grant Thornton LLP as auditor for 2026. However, the non-binding advisory vote on executive compensation received only 5,572,215 votes in favor versus 2,277,201 against, indicating significant shareholder dissent.

  • · All five Class II director nominees were elected with votes ranging from 6,068,770 (Sue Ann R. Hamilton) to 7,582,585 (John Mutch).
  • · The Charter Amendment Proposal passed with 7,719,323 votes in favor (94.9% of votes cast), leading to annual director elections starting in 2027.
  • · The Equity Plan amendment passed with 7,406,445 votes in favor (91.3% of votes cast), adding 375,000 shares and extending the plan term.
  • · The say-on-pay proposal received 5,572,215 votes in favor (70.6% of votes cast), with 2,277,201 against (28.9%), indicating notable shareholder opposition.
  • · Ratification of Grant Thornton LLP as auditor passed overwhelmingly with 9,647,501 votes in favor (98.7% of votes cast).
  • · Broker non-votes totaled 1,635,451 on all proposals except auditor ratification (which had no broker non-votes).
Raab & Moskowitz Asset Management LLC 13F-HR neutral materiality 6/10

21-05-2026

Raab & Moskowitz Asset Management LLC filed its Form 13F-HR for the quarter ended March 31, 2026, reporting a total of 187 equity holdings with an aggregate market value of approximately $449.6 million. The portfolio is heavily weighted toward large-cap ETFs and blue-chip stocks, with top positions including Vanguard Total Stock Market ETF ($21.7M), Apple Inc. ($20.1M), Berkshire Hathaway ($11.9M), and Invesco S&P 500 Equal Weight ETF ($11.2M). The filing reflects a diversified, value-oriented strategy with significant exposure to healthcare, technology, and consumer staples, though no prior-period comparison is available to assess changes in holdings.

  • · All 187 holdings are reported as sole voting and dispositive power, indicating no shared or non-discretionary accounts.
  • · The largest single equity position by market value is Vanguard Total Stock Market ETF at $21.7 million, followed by Apple Inc. at $20.1 million.
  • · The largest position by share count is Pfizer Inc. with 232,244 shares, valued at $6.5 million.
  • · The portfolio includes significant ETF exposure: Schwab US Dividend Equity ETF (146,815 shares), Vanguard Whitehall High Dividend Yield ETF (88,643 shares), and iShares Select Dividend ETF (74,238 shares).
  • · No options, warrants, or convertible securities are reported; all positions are common stocks or ETFs.
  • · The filing was signed by Daniel H. Moskowitz, Member and Chief Compliance Officer, on May 21, 2026.
Walmart Inc. 8-K mixed materiality 8/10

21-05-2026

Walmart reported strong Q1 FY27 results with revenue of $177.8B, up 7.3% (5.9% cc), and operating income growth of 5.0% (5.1% adjusted cc). eCommerce sales surged 26% globally and the advertising business grew 37%. However, free cash flow turned sharply negative at -$1.9B (down $2.4B from the prior year), and operating cash flow decreased $0.7B to $4.7B. GAAP EPS was $0.67 and adjusted EPS was $0.66. The company issued Q2 guidance (net sales +4-5% cc, adjusted op income +7-10% cc, adj. EPS $0.72-$0.74) and reiterated its full-year FY27 outlook unchanged.

  • · Gross profit rate improved 6 bps, led by Walmart U.S.
  • · Operating income negatively affected by 250 bps from higher fuel costs in distribution and fulfillment
  • · ROA at 8.4%; ROI at 14.9%, negatively affected ~45 bps from discrete items
  • · Walmart U.S. eCommerce contribution to comp sales ~530 bps, up from ~350 bps in prior year
  • · Sam's Club eCommerce contribution to comp ~400 bps, up from ~350 bps in prior year
  • · Walmart U.S. operating expense deleveraged 56 bps, reflecting higher depreciation and healthcare costs
  • · Walmart International currency fluctuation positively affected sales by $2.3B and operating income by $0.2B
  • · Sam's Club membership fee revenue grew 5.6% with steady growth in member counts, renewal rates, and Plus members
  • · Walmart U.S. inventory increased 8.0% due to timing of receipts and inventory tied to accelerated unit volume in grocery
  • · Sam's Club inventory increased 14.9%, primarily related to higher fuel costs/volumes including fuel upstreaming with a strategic partner
  • · Company raised $4.25B in long-term debt for general corporate purposes at favorable rates
BARNWELL INDUSTRIES INC 10-Q mixed materiality 7/10

21-05-2026

Barnwell Industries reported a net loss attributable to the company of $1.15M for Q2 FY2026 (three months ended March 31, 2026), narrowing from a $1.207M loss in the prior-year quarter. Revenue fell 29% to $2.535M, driven by a $1.06M decline in oil and natural gas sales. However, operating costs decreased 19% to $3.983M, and the company recorded a $338,000 equity in income of affiliates, partially offsetting the revenue drop. For the six-month period, the net loss attributable to Barnwell improved to $2.576M from $3.124M a year ago, though cash used in operations increased to $2.422M from $854M.

  • · The company issued 926,403 shares of common stock, net of costs, during the six months ended March 31, 2026, raising $3.365M.
  • · Cash used in operating activities from continuing operations increased to $2.422M in H1 FY2026 from $0.854M in H1 FY2025, a 184% increase.
  • · Capital expenditures for oil and natural gas dropped sharply to $0.25M in H1 FY2026 from $2.641M in H1 FY2025.
  • · The company recorded a $338,000 equity in income of affiliates in Q2 FY2026, compared to $0 in the prior-year quarter.
  • · Accumulated deficit widened to $9.084M at March 31, 2026 from $6.508M at September 30, 2025.
  • · Total liabilities decreased to $13.388M from $13.790M over the same period.
  • · The company had no discontinued operations in FY2026; the prior-year period included a contract drilling segment that was sold.
BARNWELL INDUSTRIES INC DEFA14A neutral materiality 5/10

21-05-2026

This DEFA14A filing is a definitive additional proxy materials notice for Barnwell Industries, Inc. (BRN) for the 2026 Annual Meeting of Stockholders to be held on June 29, 2026. Shareholders are asked to vote on six proposals including the election of six directors (all recommended 'For'), amendments to the 2018 Equity Incentive Plan to increase the available shares from 1,600,000 to 3,080,000, ratification of certain equity grants, an advisory vote on executive compensation, a non-binding vote on frequency of future advisory votes, and ratification of Weaver and Tidwell, L.L.P. as independent auditor for fiscal year ending September 30, 2026.

  • · Annual Meeting scheduled for June 29, 2026 at 10:00 AM CDT at 24 Greenway Plaza Suite 1800Q, Houston, Texas 77046.
  • · Vote deadline is June 28, 2026 at 11:59 PM ET.
  • · Shareholders can request paper/email copies of proxy materials before June 15, 2026.
  • · Proposal 2 seeks to increase shares under the 2018 Equity Incentive Plan from 1,600,000 to 3,080,000 (an increase of 1,480,000 shares).
  • · Proposal 3 seeks to ratify certain equity awards previously granted in excess of individual share limits under the 2018 Plan.
  • · Proposal 5 asks for a non-binding advisory vote on the frequency of future executive compensation votes; the Board recommends '1 Year'.
  • · The fiscal year for which the auditor is being ratified ends September 30, 2026.
  • · The filing acknowledges receipt of the 2025 Annual Report for fiscal year ended September 30, 2025.
US Mortgage-Backed & Income Fund for Puerto Rico Residents, Inc. 425 neutral materiality 6/10

21-05-2026

Fourteen Puerto Rico closed-end funds announced a strategic review to pursue mergers with open-end funds to provide better liquidity and operational efficiencies. The boards are evaluating mergers that would allow daily redemptions at NAV, subject to shareholder approval and regulatory filings. If mergers are not approved, the boards will explore other alternatives to enhance liquidity.

  • · The funds are unlisted closed-end funds registered under the Investment Company Act of 1940.
  • · A merger would require shareholder approval and a registration statement on Form N-14.
  • · If a merger is not approved, the board will examine other strategic alternatives to provide liquidity at or close to NAV.
  • · The announcement was made on May 20, 2026, from San Juan, Puerto Rico.
Ivanhoe Electric Inc. 8-K neutral materiality 3/10

21-05-2026

Ivanhoe Electric Inc. disclosed that its majority-owned subsidiary Cordoba Minerals Corp. entered into a consulting agreement with Quentin Markin as interim CEO, effective May 20, 2026. Mr. Markin will receive a monthly fee of $7,500 plus expense reimbursement. The agreement terminates upon appointment of a new CEO or by notice. Mr. Markin continues as EVP of Business Development and Strategy Execution at Ivanhoe Electric and as a Cordoba Minerals director.

  • · The consulting agreement was entered into on May 20, 2026, retroactively covering services since Mr. Markin's appointment as interim CEO on March 6, 2026.
  • · The agreement can be terminated for cause by Cordoba Minerals or without cause by either party with one month's written notice.
  • · Mr. Markin also serves as a director of Cordoba Minerals.
BARNWELL INDUSTRIES INC DEF 14A neutral materiality 5/10

21-05-2026

Barnwell Industries, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders, scheduled for a date to be determined, with a record date of May 4, 2026, and 14,338,575 shares of common stock issued and outstanding. The meeting will include six proposals: election of directors, approval of amendments to the 2018 Equity Incentive Plan, ratification of equity awards granted in excess of individual share limits, an advisory vote on executive compensation, an advisory vote on the frequency of the say-on-pay vote, and ratification of Weaver and Tidwell, L.L.P. as the independent auditor for fiscal year 2026. The proxy statement provides detailed executive compensation information for the fiscal year ended September 30, 2025, but the filing does not include specific financial performance metrics or period-over-period comparisons, limiting the ability to assess company performance trends.

  • · The proxy materials are being distributed on or about May 20, 2026.
  • · Stockholders of record as of May 4, 2026 are entitled to vote.
  • · A quorum requires a majority of issued and outstanding shares.
  • · Proposal 1 (Election of Directors) requires a plurality vote; abstentions and broker non-votes have no effect.
  • · Proposal 2 (Amendments to 2018 Plan) requires a majority of shares present; abstentions count as votes against.
  • · Proposal 3 (Ratification of Excess Awards) requires a majority of shares present; abstentions count as votes against.
  • · Proposal 4 (Advisory Say-on-Pay) is non-binding and requires a majority of shares present; broker non-votes have no effect.
  • · Proposal 5 (Frequency of Say-on-Pay) is advisory and non-binding.
  • · Proposal 6 (Ratification of Auditor) is a routine matter where brokers may vote without instructions.
  • · No cumulative voting rights exist for common stockholders.
Perella Weinberg Partners 8-K neutral materiality 5/10

21-05-2026

Perella Weinberg Partners issued 1,908,084 shares of Class A common stock in exchange for 1,906,191 Class A partnership units of PWP OpCo and an equal number of Class B common shares held by certain limited partners. The exchange was conducted under the PWP OpCo LPA and exempt from registration under Section 4(a)(2) of the Securities Act. No financial performance data or period-over-period comparisons are included in this filing.

  • · The exchange was at the option of the Company, which could deliver cash or Class A common stock to exchanging unitholders.
  • · Class B common stock converts to Class A common stock at a ratio of 1:1000 (0.001) upon exchange.
  • · The issuance was made in reliance on Section 4(a)(2) of the Securities Act as a non-public offering.
BRAINSTORM CELL THERAPEUTICS INC. S-1 mixed materiality 8/10

21-05-2026

Brainstorm Cell Therapeutics Inc. filed an S-1 registration statement on May 21, 2026, for a proposed public offering of securities to be sold by selling stockholders on a delayed or continuous basis. The company, a clinical-stage biotechnology firm focused on cellular therapies, reported a net loss of $22.589 million for the year ended December 31, 2025, compared to a net loss of $22.589 million in 2024, indicating flat performance. The filing also details significant financing activities, including convertible notes and short-term loans, and highlights the company's need for additional capital to fund operations.

  • · The company is a smaller reporting company and a non-accelerated filer.
  • · The registration statement is subject to completion and dated May 2, 2026.
  • · The offering involves selling stockholders and may be conducted on a delayed or continuous basis under Rule 415.
  • · The filing includes details of convertible promissory notes issued in October and November 2025, and subsequent events in January and May 2026.
  • · The company has a history of net losses and expects to continue incurring losses.
FORD MOTOR CO 8-K neutral materiality 7/10

21-05-2026

Ford Motor Company entered into a Loan Arrangement and Reimbursement Agreement with the U.S. Department of Energy (DOE) on May 20, 2026, under the Advanced Technology Vehicles Manufacturing (ATVM) Program. The agreement relates to the restructuring of the BlueOval SK joint venture, whereby Ford will acquire two battery manufacturing facilities in Hardin County, Kentucky, and assume related debt, including the Original Note from BOSK. The filing does not disclose the loan amount or financial terms, but the transaction involves the assumption of existing indebtedness and the acquisition of facilities for advanced vehicle battery production.

  • · The agreement was executed on May 20, 2026, and filed on May 21, 2026.
  • · The transaction involves the restructuring of the BlueOval SK joint venture, with Ford exiting its 50% ownership and acquiring two Kentucky battery facilities.
  • · Ford's subsidiary, Ford Energy Battery LLC, will acquire BOSK's leasehold interest in the Kentucky facilities and assume the Original Note.
  • · The BOSK Loan Agreement was originally dated December 13, 2024, and amended on November 21, 2025.
  • · The facilities are subject to existing mortgages (Existing KY Fee Mortgage and Existing KY Leasehold Mortgage) that secure the Note.
  • · The agreement includes standard representations, warranties, and covenants, including a minimum liquidity covenant (Section 9.01).
CONSTELLATION BRANDS, INC. 8-K positive materiality 4/10

21-05-2026

Constellation Brands elected Morgan Flatley, Executive Vice President and Global CMO of McDonald's, as an independent director effective May 20, 2026, returning the board to twelve members after Bill Newlands' retirement. Flatley brings extensive global brand-building experience from McDonald's and PepsiCo, which the company expects to support its position as the #1 high-end beer supplier in the U.S. by dollar sales. The filing contains no financial results or negative performance metrics.

  • · Flatley has been named to the Forbes World's Most Influential CMOs list multiple times and received Adweek's Brand Genius honor.
  • · Prior to McDonald's, Flatley spent 13 years at PepsiCo, most recently as SVP and CMO of Global Nutrition for Quaker, Tropicana, Gatorade, and Naked Juice.
  • · Constellation Brands operates in the U.S., Mexico, New Zealand, and Italy.
  • · The company describes itself as one of the fastest-growing large CPG companies in the U.S. at retail.
KPET Ultra Paceline Corp 8-K neutral materiality 3/10

21-05-2026

KPET Ultra Paceline Corporation announced that holders of its units may elect to separately trade the Class A ordinary shares and warrants included in the units, commencing May 21, 2026. The separated shares and warrants will trade on the NYSE under symbols 'KPET' and 'KPET.WS', respectively, while units not separated will continue to trade under 'KPET.U'. The company is a blank check company formed for a business combination, sponsored by KPET Ultra Paceline LLC, and has not yet identified a target business.

  • · The registration statement for the securities was declared effective by the SEC on March 30, 2026.
  • · No fractional warrants will be issued upon separation; only whole warrants will trade.
  • · The company is a blank check company (SIC 6770) incorporated in E9 (likely Cayman Islands) with fiscal year end December 31.
  • · The company's sponsor is KPET Ultra Paceline LLC, controlled by Eduardo Tamraz and KPThree Capital LLC (controlled by Karl Peterson).
  • · In 2024, Messrs. Peterson and Tamraz led a group of family offices that invested in IRA Financial, a South Dakota-chartered trust company.
PepGen Inc. 8-K neutral materiality 3/10

21-05-2026

PepGen Inc. furnished an updated Corporate Presentation on May 21, 2026, in connection with its participation in the 15th International Myotonic Dystrophy Consortium (May 26-30, 2026). The filing is a Regulation FD disclosure and does not contain any financial results or quantitative performance data.

  • · The updated Corporate Presentation was furnished as Exhibit 99.1 and is incorporated by reference.
  • · The presentation is being used at the 15th International Myotonic Dystrophy Consortium held May 26-30, 2026.
  • · The information is furnished, not filed, under the Exchange Act and is not subject to Section 18 liabilities.
Teladoc Health, Inc. 8-K neutral materiality 3/10

21-05-2026

Teladoc Health held its 2026 Annual Meeting on May 21, 2026, where stockholders elected eight director nominees, approved executive compensation on an advisory basis, and ratified Ernst & Young as independent auditor. All proposals passed, though director David B. Snow, Jr. received significant opposition with 12.9 million against votes.

  • · David B. Snow, Jr. received the lowest support among directors with 67,368,308 for, 12,899,237 against, and 1,018,096 abstentions.
  • · Proposal 2 (say-on-pay) passed with 71,154,268 for, 8,973,257 against, and 1,158,116 abstentions.
  • · Proposal 3 (auditor ratification) passed overwhelmingly with 122,580,992 for, 1,195,800 against, and 716,057 abstentions.
  • · Broker non-votes were 43,207,208 for Proposals 1 and 2, and not applicable for Proposal 3.
Northfield Bancorp, Inc. DEFM14A neutral materiality 8/10

21-05-2026

This joint proxy statement/prospectus relates to the proposed merger of Northfield Bancorp, Inc. (NFBK) into Columbia Financial, Inc. Northfield Bancorp stockholders will vote on the merger proposal, a non-binding advisory vote on merger-related compensation, and an adjournment proposal. The Northfield Bancorp board unanimously recommends voting FOR all proposals, and board members holding approximately 4.0% of outstanding shares have entered into support agreements to vote in favor of the merger.

  • · The Northfield Bancorp Special Meeting will be held virtually on June 25, 2026 at 9:00 a.m. Eastern time.
  • · Record date for the Northfield Bancorp Special Meeting is April 27, 2026.
  • · Internet and telephone voting closes at 11:59 p.m. Eastern time on June 24, 2026.
  • · Northfield Bank ESOP and 401(k) Plan voting instructions deadline is 11:59 p.m. Eastern time on June 18, 2026.
  • · Approval of the Northfield Merger Proposal requires the affirmative vote of a majority of outstanding shares.
  • · The Northfield Merger-Related Compensation Proposal and Adjournment Proposal require a majority of votes cast.
  • · All three proposals are considered non-routine under NYSE rules, meaning brokers cannot vote uninstructed shares.
  • · The Columbia Financial board unanimously recommends a vote FOR the say-on-pay proposal and a frequency of one year for say-on-pay votes.
TRAVELERS COMPANIES, INC. 8-K neutral materiality 6/10

21-05-2026

Travelers Companies entered into a new $1.2 billion five-year revolving credit agreement on May 15, 2026, replacing its prior $1.0 billion facility. The new credit line, which matures on May 15, 2031, can be increased up to $1.8 billion with lender consent and is intended for general corporate purposes. The company must maintain consolidated net worth in excess of goodwill and intangible assets of at least $17.8 billion under the agreement.

  • · The credit agreement includes customary restrictive covenants and events of default, including a change-in-control provision.
  • · Interest rates are based on base rate plus a margin or SOFR plus a margin, with facility fees varying by the company's long-term senior unsecured debt ratings.
  • · The facility can be extended beyond May 15, 2031 with lender consent.
  • · Certain lenders or their affiliates have provided and may continue to provide commercial and investment banking services to Travelers.
MOHAWK INDUSTRIES INC 8-K mixed materiality 6/10

21-05-2026

Mohawk Industries held its 2026 Annual Meeting on May 21, 2026, where stockholders approved the 2026 Incentive Plan, elected three directors, ratified KPMG as auditor, and approved executive compensation on an advisory basis. All director nominees received strong support, with Jeffrey S. Lorberbaum receiving 51,075,758 votes for (97.4% of votes cast), while Karen A. Smith Bogart received 42,231,791 votes for (80.3% of votes cast), indicating some shareholder dissent. The advisory vote on executive compensation passed with 48,793,836 votes for (92.9% of votes cast), but 3,732,023 votes against (7.1%) show notable opposition. A stockholder proposal on majority vote standard was not acted upon due to the proponent's absence.

  • · The 2026 Incentive Plan will terminate on May 21, 2036, unless extended with shareholder approval.
  • · The 2026 Plan allows grants of options, stock appreciation rights, restricted stock, restricted stock units, deferred stock units, performance awards, dividend equivalent rights, other equity-based awards, and cash-based awards.
  • · Shares reserved under the 2026 Plan are reduced by one share for each share awarded under the Prior Plan after December 31, 2025 and before May 21, 2026.
  • · A stockholder proposal regarding a majority vote standard was not acted upon because the proponent or a qualified representative did not attend the Annual Meeting.
  • · Broker non-votes totaled 2,725,067 on director elections, advisory compensation, and the 2026 Plan.
JPMORGAN CHASE & CO 8-K mixed materiality 5/10

21-05-2026

JPMorgan Chase & Co. held its Annual Meeting of Shareholders on May 19, 2026, with 85.17% of shares represented. All 11 director nominees were elected with at least 92.37% of votes cast, and shareholders approved executive compensation (92.35% for) and ratified PwC as auditor (92.79% for). However, all four shareholder proposals were rejected by wide margins, including the independent board chairman proposal which received only 35.11% support.

  • · All 11 director nominees received at least 92.37% of votes cast, with Alicia Boler Davis receiving the highest support (1,915,243,359 for) and Stephen B. Burke the lowest (1,777,524,386 for).
  • · The advisory vote on executive compensation passed with 92.35% for, 7.23% against, and 0.42% abstain.
  • · Ratification of PwC as independent auditor for 2026 passed with 92.79% for, 7.00% against, and 0.21% abstain.
  • · The shareholder proposal for an independent board chairman received 35.11% support, the highest among the four shareholder proposals.
  • · The proposal on lobbying alignment received 13.20% support, while climate initiatives report and sustainability ROI report proposals each received less than 2% support.
Braemar Hotels & Resorts Inc. 8-K neutral materiality 3/10

21-05-2026

Braemar Hotels & Resorts Inc. announced on May 21, 2026, that its Board of Directors declared the May 2026 portion of the second quarter 2026 dividends for its Series B, Series D, Series E, and Series M preferred stocks. As of April 30, 2026, there were 11,146,482 shares of Series E and 1,373,463 shares of Series M preferred stock outstanding. The filing is a routine dividend declaration with no negative or flat performance metrics disclosed.

  • · Dividends declared for May 2026 portion of Q2 2026 for Series B, D, E, and M preferred stocks.
  • · Series E and M preferred stock share counts provided as of April 30, 2026.
KORU Medical Systems, Inc. 8-K positive materiality 5/10

21-05-2026

KORU Medical Systems, Inc. held its 2026 Annual Meeting of Shareholders on May 19, 2026, with 36,678,784 total shares voted. All seven director nominees were elected, and shareholders approved an amendment to the 2024 Omnibus Equity Incentive Plan to increase available shares, as well as advisory approval of executive compensation and a one-year frequency for future say-on-pay votes. The appointment of Cherry Bekaert LLP as independent auditor for fiscal 2026 was ratified with overwhelming support (36,500,510 votes for).

  • · Proposal 1: All seven director nominees were elected with strong support; the lowest 'for' votes were 25,202,422 for R. John Fletcher, while Donna French received the highest at 25,801,738.
  • · Proposal 2: The amendment to the 2024 Omnibus Equity Incentive Plan passed with 25,018,973 votes for, 826,145 against, and 13,016 abstentions.
  • · Proposal 3: Advisory approval of executive compensation passed with 25,723,379 votes for, 91,649 against, and 43,106 abstentions.
  • · Proposal 4: Shareholders approved a one-year frequency for future advisory votes on executive compensation (24,865,692 votes for 1 year, 61,741 for 2 years, 916,055 for 3 years, 14,646 abstentions).
  • · Proposal 5: Ratification of Cherry Bekaert LLP as independent auditor for fiscal 2026 passed with 36,500,510 votes for, 19,629 against, and 158,645 abstentions.
Wellgistics Health, Inc. 8-K neutral materiality 3/10

21-05-2026

Wellgistics Health, Inc. filed an 8-K on May 21, 2026, announcing a letter to shareholders regarding its strategy overview and business update. The filing does not disclose any specific financial figures, performance metrics, or material changes, and no quantitative data or period comparisons are provided.

  • · The letter to shareholders is attached as Exhibit 99.1 and incorporated by reference.
  • · The filing is made under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits).
  • · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.
TPG RE Finance Trust, Inc. 8-K mixed materiality 6/10

21-05-2026

TPG RE Finance Trust, Inc. held its 2026 Annual Meeting on May 19, 2026, where stockholders elected eight directors, ratified Deloitte & Touche LLP as independent auditor for 2026, and approved executive compensation on an advisory basis. Notably, director Edward 'Ted' Goldthorpe received more votes withheld (21,008,312) than votes for (20,679,430), indicating significant shareholder dissent, while all other directors were elected with strong support.

  • · Proposal 2 (ratification of Deloitte) passed with 49,184,930 votes for, 8,063,066 against, and 1,106,844 abstentions.
  • · Proposal 3 (advisory vote on executive compensation) passed with 39,445,446 votes for, 1,072,158 against, and 1,170,138 abstentions, with 16,667,098 broker non-votes.
  • · Broker non-votes were 16,667,098 for all director elections and the advisory compensation vote.
  • · The meeting was held on May 19, 2026, and the 8-K was filed on May 21, 2026.
WHITE MOUNTAINS INSURANCE GROUP LTD 8-K neutral materiality 5/10

21-05-2026

White Mountains Insurance Group held its 2026 Annual General Meeting on May 21, 2026, where all four Class II director nominees (Liam P. Caffrey, Mary C. Choksi, John K. Chu, and Weston M. Hicks) were elected. Director Steven M. Yi did not stand for re-election and completed his tenure. The advisory resolution on executive compensation passed with 98% approval (1,993,894 votes for), and PricewaterhouseCoopers LLP was ratified as the independent auditor for 2026. Notably, director Weston M. Hicks received significant opposition with 167,615 votes against (8.2%), the highest against any nominee.

  • · Director Weston M. Hicks received 167,615 votes against (8.2% of votes cast), compared to other nominees who received between 28,706 and 112,006 votes against.
  • · Broker non-votes totaled 223,336 on all director elections and the executive compensation advisory vote, representing about 9.0% of outstanding shares.
  • · The independent auditor ratification (Proposal 3) had no broker non-votes and passed with 2,186,203 votes for, 69,271 against, and 2,180 abstentions.
  • · Director Steven M. Yi's departure is due to not standing for re-election, not a contested removal.
KKR Private Equity Conglomerate LLC 8-K neutral materiality 5/10

21-05-2026

KKR Private Equity Conglomerate LLC disclosed its transactional net asset values per share as of April 30, 2026, ranging from $34.18 (Class R-U) to $37.19 (Class G and H). The filing provides a snapshot of per-share valuations across multiple share classes, with no prior period comparison available to assess performance trends.

  • · No Class R-S or Class E shares were outstanding as of April 30, 2026.
  • · The Transactional Net Asset Value is used for sales and repurchases of the Company's shares.
  • · The NAV is also available on the Company's website at www.kkrpec.com.
ClearSign Technologies Corp 8-K mixed materiality 6/10

21-05-2026

ClearSign Technologies reported $7.7 million in cash and cash equivalents as of March 31, 2026, with 5,409,133 shares outstanding after a 1-for-10 reverse stock split. The company secured multiple orders, including a fifth low-emission flare order from a California energy company and an M1 burner order for West Texas, and successfully completed DOE/SBIR flexible fuel burner testing. However, no revenue or net income figures were disclosed, and the company continues to operate with limited cash resources relative to its growth ambitions.

  • · The company completed a 1-for-10 reverse stock split effective March 16, 2026.
  • · The M1 burner order for West Texas is expected to be delivered in Q3 2026.
  • · The fifth low-emission flare order includes upgraded flare technology, stack components, and control upgrades.
  • · The company will host a conference call on May 20, 2026 at 5:00 PM ET with Q&A session.
  • · No revenue or net income figures were provided in the update.
ClearPoint Neuro, Inc. 8-K neutral materiality 4/10

21-05-2026

ClearPoint Neuro held its Annual Meeting on May 20, 2026, where stockholders approved the Seventh Amended and Restated 2013 Incentive Compensation Plan, ratified Cherry Bekaert LLP as auditors, and elected seven directors. The Board appointed committee memberships and confirmed R. John Fletcher as Chairman. No financial results were disclosed.

  • · All seven director nominees received over 9.6 million votes for, with broker non-votes of 9,991,790.
  • · Ratification of auditors passed with 19,296,330 for, 20,086 against, 482,057 abstentions, and no broker non-votes.
  • · Advisory vote on executive compensation: 8,825,126 for, 442,728 against, 538,829 abstentions, 9,991,790 broker non-votes.
  • · Approval of incentive compensation plan: 7,517,634 for, 1,793,261 against, 495,788 abstentions, 9,991,790 broker non-votes.
  • · The Board determined all committee members are independent under Nasdaq rules; R. John Fletcher qualifies as an audit committee financial expert.
Monroe Capital Income Plus Corp 8-K neutral materiality 5/10

21-05-2026

Monroe Capital Income Plus Corp issued 1,174,995 shares of common stock at $9.77 per share for aggregate proceeds of $11.48M on May 1, 2026. The board declared a dividend of $0.071 per share payable on May 27, 2026. Net asset value per share as of April 30, 2026 is $9.77.

  • · Stock issuance exempt under Section 4(a)(2) and Regulation D or S.
  • · Dividend record date is May 21, 2026, payable on or about May 27, 2026.
  • · Net asset value per share as of April 30, 2026 is $9.77, equal to the issuance price.
Kraft Heinz Co 8-K neutral materiality 6/10

21-05-2026

Kraft Heinz announced early tender results for its cash tender offer to purchase up to $1.1B aggregate principal of its 4.375% Senior Notes due 2046 and 4.875% Senior Notes due 2049. As of the early tender deadline, $1.752B of the 2046 Notes and $822.6M of the 2049 Notes were tendered, exceeding the maximum amount, so proration is expected. The company satisfied the financing condition and elected early settlement on May 26, 2026.

  • · Early tender deadline was 5:00 p.m. NYC time on May 20, 2026.
  • · Withdrawal deadline passed on May 20, 2026; tendered notes can no longer be withdrawn.
  • · Price Determination Date is May 21, 2026 at 10:00 a.m. NYC time.
  • · Tender Offer expires on June 5, 2026 at 5:00 p.m. NYC time unless extended.
  • · Notes tendered after early tender time will not be accepted.
  • · Proration will apply if aggregate purchase price exceeds Maximum Tender Amount.
  • · Dealer Managers include BofA Securities, Citigroup, Deutsche Bank Securities, and Goldman Sachs.
KKR Infrastructure Conglomerate LLC 8-K neutral materiality 5/10

21-05-2026

KKR Infrastructure Conglomerate LLC disclosed its Transactional Net Asset Values per share by class as of April 30, 2026. Valuations range from $30.30 (Class U) to $35.74 (Classes G and H), representing the prices at which share sales and repurchases are transacted. No Class R-S, Class R-D or Class E shares were outstanding as of that date.

  • · The filing was made as an 8-K under Items 8.01 and 9.01, categorizing it as an 'Other Events' disclosure.
  • · No Class R-S, Class R-D or Class E shares were outstanding as of April 30, 2026.
  • · The Transactional NAV per share is also published on the company’s website at www.kinfra.com, though the website content is not incorporated by reference in the filing.
  • · The company is an emerging growth company as defined under securities rules.
  • · The address of principal executive offices is 30 Hudson Yards, New York, NY 10001.
GABELLI DIVIDEND & INCOME TRUST DEFA14A mixed materiality 8/10

21-05-2026

The Gabelli Dividend & Income Trust (GDV) mailed a letter to shareholders on May 21, 2026, urging them to vote on the WHITE proxy card in a contested election against activist Saba Capital Management, which seeks to place its own nominee on the Board. The Fund highlights strong performance—GDV is up over 29% in the twelve months ended May 5, 2026, and has averaged 8.8% annually since inception—and a current distribution rate of $1.80 per share (6.2% yield). However, the letter warns that if shareholders do not vote, their shares will not automatically support the Board's recommendation, effectively giving Saba a free pass.

  • · The annual meeting has been adjourned until Monday, June 29, 2026.
  • · Shareholders are instructed to discard any GOLD proxy card sent by Saba; voting Saba's card cancels a previously submitted WHITE proxy card vote.
  • · The Fund's proxy solicitation firm is EQ Fund Solutions, reachable at 1 (888) 886-4425.
  • · The Fund has paid cumulative cash distributions of $28.40 per share since inception.
  • · The annual distribution rate has increased 36% since the end of 2023.
CHOICE HOTELS INTERNATIONAL INC /DE 8-K neutral materiality 3/10

21-05-2026

The filing is an 8-K announcing a third amendment to the Restated Certificate of Incorporation of Choice Hotels International, Inc., filed on May 21, 2026. The amendment revises the minimum number of directors on the board from 5 to a range of

  • · The original Certificate of Incorporation was filed on December 12, 1980.
  • · The Restated Certificate was previously amended on April 30, 2013 and May 16, 2024.
  • · The amendment was adopted and approved by the Board of Directors and by holders of requisite shares per Delaware General Corporation Law Section 242.
  • · The amendment became effective upon filing with the Secretary of State of Delaware on May 21, 2026.
  • · All other provisions of the Restated Certificate remain unchanged.
BICYCLE THERAPEUTICS PLC 8-K neutral materiality 5/10

21-05-2026

Bicycle Therapeutics plc announced initial Duravelo-2 data for metastatic urothelial cancer at the 2026 ASCO Annual Meeting on May 21, 2026. The press release provides early clinical results for the company's lead candidate, but no specific financial or quantitative performance metrics were disclosed in the filing.

  • · The press release was issued on May 21, 2026.
  • · The data was presented at the 2026 ASCO Annual Meeting.
  • · The filing does not include any financial results or forward-looking guidance.
TPG Twin Brook Capital Income Fund 8-K mixed materiality 7/10

21-05-2026

TPG Twin Brook Capital Income Fund (TCAP) reported strong Q1 2026 performance, generating a 2.5% year-to-date total return (Class I), outperforming leveraged loans by 180bps and fixed income by 250bps. The portfolio remains resilient with 100% first lien senior secured debt, low non-accruals (0.2% at cost), and low PIK interest (1.3%). However, direct lending market volumes declined ~30% quarter-over-quarter and year-over-year, and competitive dynamics continue to pressure spreads, though TCAP's weighted average spread increased 10bps to 540bps.

  • · 100% of TCAP's portfolio is first lien senior secured debt.
  • · 100% of loans have covenants and revolvers.
  • · 100% of loans are to private equity sponsored companies.
  • · TCAP is sole or lead lender for nearly all loans.
  • · Interest coverage ratio is 2.4x.
  • · Average position size is 0.37%.
  • · Floating rate investments are ~100%.
  • · Private investments (Level 3) are 100%.
  • · Weighted average yield is 8.8%.
  • · Inception-to-date selectivity ratio is <4%.
  • · Lower middle market spread premium per turn of leverage is ~35 bps.
  • · Share of private credit fundraising is 43%.
  • · Share of LBOs financed in private credit markets is 82%.
  • · Lower middle market share of M&A volume is 37%.
  • · Share of lower middle market activity represented by M&A volume is 70%.
  • · Market size of direct lending is $1.4 trillion.
  • · Class S ITD total return with upfront fee is 8.6%, without is 10.1%.
  • · Class D ITD total return with upfront fee is 9.9%, without is 10.6%.
Kontoor Brands, Inc. 8-K mixed materiality 9/10

21-05-2026

Kontoor Brands, Inc. (KTB) has entered into a definitive agreement to sell its Lee® business to Authentic Brands Group for up to $1 billion, comprising an initial $750 million and a $250 million earnout. The transaction, unanimously approved by Kontoor's board, is expected to close in the second half of 2026 and will allow Kontoor to focus on its higher-growth Wrangler® and Helly Hansen® brands. However, the sale is subject to regulatory approvals and customary closing conditions, and the company faces risks related to tariffs, macroeconomic conditions, and integration challenges.

  • · Transaction proceeds are anticipated to be deployed through increased share repurchases under the existing $750 million authorization and voluntary term loan payments.
  • · The transaction was unanimously approved by Kontoor's Board of Directors.
  • · Kontoor has published further details in a presentation accessible at https://www.kontoorbrands.com/investors.
  • · Morgan Stanley & Co. LLC served as exclusive financial advisor and Foley & Lardner LLP as legal advisor.
Relay Therapeutics, Inc. 8-K positive materiality 8/10

21-05-2026

Relay Therapeutics, Inc. entered into an underwriting agreement on May 20, 2026, for a public offering of 22,916,667 shares of common stock at $12.00 per share, with the underwriters fully exercising their 30-day option to purchase an additional 3,437,500 shares on May 21, 2026. The company estimates net proceeds of approximately $296.8 million after deducting underwriting discounts and commissions and other expenses. The offering is expected to close on May 22, 2026, subject to customary conditions.

  • · The offering was made under the company's effective shelf registration statement on Form S-3ASR (File No. 333-281308), including the prospectus dated August 6, 2024, as supplemented by a prospectus supplement dated May 20, 2026.
  • · The underwriters' option to purchase additional shares was exercised in full on May 21, 2026.
  • · The underwriting agreement includes customary representations, warranties, and covenants, as well as indemnification of the underwriters against certain liabilities, including under the Securities Act of 1933.
BlackRock ESG Capital Allocation Term Trust DEFA14A positive materiality 8/10

21-05-2026

Glass Lewis, a leading independent proxy advisory firm, has recommended that shareholders of BlackRock ESG Capital Allocation Term Trust (ECAT) vote on the WHITE proxy card FOR all nine of the Fund's board nominees ahead of the June 9, 2026 annual meeting, rejecting the dissident Saba's full slate. Glass Lewis noted ECAT's discount (near 2.8% as of May 15, 2026) and distribution rate as 'functionally best-in-class' and highlighted that Saba sold down nearly a third of its stake after failing to gather meaningful investor coalition. The Fund has outperformed its peer group by 36% since 2023 and averaged the lowest discount among competitor funds.

  • · Glass Lewis rejected the dissident's full slate of nominees.
  • · Saba sold down nearly a third of its stake after failing to gather meaningful investor coalition.
  • · ECAT has averaged the lowest discount to net asset value among competitor funds (Morningstar data as of April 30, 2026).
  • · Only the latest dated proxy will count at the meeting; shareholders should not send back any proxy card other than the one from BlackRock.
  • · The annual meeting is scheduled for June 9, 2026.
  • · Shareholders can vote via website, toll-free number, or by returning the WHITE proxy card.
  • · BlackRock's proxy solicitor is Georgeson LLC (toll-free: (866) 961-8444).
Summit Hotel Properties, Inc. 8-K neutral materiality 3/10

21-05-2026

Summit Hotel Properties, Inc. held its Annual Meeting of Stockholders on May 20, 2026, with 93,766,794 shares of common stock represented (86.18% of outstanding shares). All eight director nominees were elected, and stockholders ratified Ernst & Young LLP as the independent auditor for fiscal 2026 and approved, on a non-binding advisory basis, the compensation of named executive officers.

  • · The record date for the Annual Meeting was March 6, 2026.
  • · Broker non-votes totaled 6,836,587 for each director election and the advisory compensation vote.
  • · Hope S. Taitz received the lowest number of 'For' votes among director nominees (84,046,485) and the highest number of 'Against' votes (2,582,862) and abstentions (300,860).
  • · The ratification of Ernst & Young LLP received 93,403,656 votes 'For', 344,623 'Against', and 18,515 abstentions, with no broker non-votes.
  • · The advisory vote on executive compensation received 86,318,666 'For', 595,598 'Against', and 15,943 abstentions.
Pelthos Therapeutics Inc. 8-K neutral materiality 6/10

21-05-2026

Pelthos Therapeutics Inc. (PTHS) dismissed its independent auditor CBIZ CPAs P.C. and engaged Grant Thornton LLP as its new auditor for fiscal year 2026, effective May 16, 2026. Separately, the Company entered into a Separation Agreement with former CFO Francis Knuettel II, providing $430,000 in severance pay and accelerated vesting of stock options and RSUs. No disagreements or reportable events occurred with the former auditor, and no prior consultations were made with Grant Thornton.

  • · CBIZ acquired Marcum LLP's attest business effective November 1, 2024; Marcum had audited the Company's 2024 financials.
  • · The audit report for fiscal year ended December 31, 2025 contained no adverse opinion or qualification.
  • · No disagreements or reportable events occurred with CBIZ during fiscal years 2024, 2025, or the interim period through May 18, 2026.
  • · Grant Thornton was engaged for fiscal year ending December 31, 2026 and related interim periods.
  • · The Company had no prior consultations with Grant Thornton regarding accounting principles or audit opinions.
  • · The Separation Agreement includes a general release of claims, confidentiality, non-disparagement, and cooperation obligations.
  • · The Separation Agreement becomes effective after a 7-day revocation period following the May 15, 2026 execution date.
Black Diamond Therapeutics, Inc. 8-K positive materiality 8/10

21-05-2026

Black Diamond Therapeutics announced positive Phase 2 results for silevertinib in frontline NSCLC patients with EGFR non-classical mutations. Key efficacy data include a preliminary median progression-free survival of 15.2 months, a 60% objective response rate, and a 91% disease control rate, with no new safety signals observed. However, 28% of patients experienced treatment-related adverse events > Grade 3 after dose reduction, and the study remains ongoing with a median follow-up of 11.2 months.

  • · Median duration of response (DOR) had not been reached (95% CI: 7.0, NE).
  • · Longest time on therapy is 23.5 months.
  • · No patients developed de novo brain metastases.
  • · Variant allele frequency reduction observed in all evaluable patients across 25 unique EGFR-NCMs, including PACC.
  • · Safety and efficacy data support 150 mg QD for pivotal development.
  • · The study remains ongoing with a median follow-up of 11.2 months as of April 11, 2026 data cutoff.
KOHLS Corp 8-K mixed materiality 7/10

21-05-2026

Kohl's Corporation held its 2026 Annual Meeting on May 20, 2026, where shareholders approved the amended 2024 Long-Term Compensation Plan, increasing authorized shares by 5.2M to a total of 12.85M and extending the plan through 2036. All eight director nominees were elected, and the advisory vote on executive compensation passed with 66.5M for vs 4.0M against)Skip. However, the ratification of Ernst & Young as auditor received 86.8M for vs 3.7M against, and the compensation plan approval saw 67.4M for vs 3.3M against, with broker non-votes of 19.8M on all proposals except the auditor ratification.

  • · The Plan extends through May 20, 2036 (10-year term).
  • · The Plan allows grants of stock options, stock appreciation rights, stock awards, performance units, performance shares, and substitute awards.
  • · Proposal 1 (Director Election): All eight nominees received over 65.8M votes for, with the lowest being Yael Cosset at 65.8M for vs 4.9M against.
  • · Proposal 2 (Advisory Vote on Executive Compensation): 66.5M for, 4.0M against, 0.4M abstentions.
  • · Proposal 3 (Ratification of Auditor): 86.8M for, 3.7M against, 0.3M abstentions (no broker non-votes).
  • · Proposal 4 (Plan Approval): 67.4M for, 3.3M against, 0.3M abstentions.
  • · Broker non-votes of 19.8M were recorded on Proposals 1, 2, and 4.
BBCMS Mortgage Trust 2026-5C41 8-K neutral materiality 6/10

21-05-2026

BBCMS Mortgage Trust 2026-5C41 issued $472,934,000 in Public Certificates and $478,630,601.10 in total net proceeds from the sale of all certificates, backed by 33 commercial, multifamily, and manufactured housing community mortgage loans. The Retaining Sponsor, BSPRT CMBS Finance, LLC, is retaining a horizontal residual interest with a fair value of $27,405,568 (5.027% of total fair value) to satisfy credit risk retention requirements, slightly above the required 5.0% threshold of $27,257,797. However, expenses totaled $6,314,344.75, including $6,093,938.99 in other expenses, which may indicate higher-than-expected costs.

  • · The Pooling and Servicing Agreement is dated and effective as of May 1, 2026.
  • · The Underwriting Agreement and Certificate Purchase Agreement were both dated April 30, 2026.
  • · The registration statement (file no. 333-286968) was originally declared effective on May 23, 2025.
  • · The legal opinion and tax opinion were rendered by Cadwalader, Wickersham & Taft LLP on May 21, 2026.
  • · The Retaining Sponsor is BSPRT CMBS Finance, LLC, and the majority-owned affiliate holding the HRR Certificates is BSP B-Equity Ventures, LLC.
  • · There are no material differences between the fair value methodology disclosed in the Preliminary Prospectus (April 27, 2026) and the final fair value calculation.
Thermon Group Holdings, Inc. 10-K mixed materiality 8/10

21-05-2026

Thermon Group Holdings, Inc. reported sales of $536.3M for fiscal year 2026, an 8% increase from $498.2M in FY2025, driven by gross margin expansion to 45.3%. However, net income declined 17% to $44.6M from $53.5M, as selling, general and administrative expenses surged 22% and the effective tax rate rose to 30.6% from 23.7%. Adjusted EBITDA grew 9% to $119.6M, and adjusted diluted EPS increased 15% to $2.15, but free cash flow fell 38% to $32.9M.

  • · Total assets increased to $830.6M as of March 31, 2026 from $755.5M a year earlier.
  • · Total equity rose to $538.7M from $495.3M.
  • · Cash and cash equivalents grew to $52.3M from $39.5M.
  • · Inventories increased to $118.1M from $89.0M.
  • · Goodwill stood at $269.0M, up from $264.3M.
  • · Total debt (current portion + revolver + long-term) was $141.1M as of March 31, 2026, compared to $138.4M a year earlier.
  • · The company repurchased shares, with treasury stock increasing to $36.2M from $20.4M.
  • · Transaction-related costs in FY2026 were $12.9M, up from $0.4M in FY2025.
  • · ERP implementation-related costs were $1.9M in FY2026 versus $0.6M in FY2025.
  • · Depreciation and amortization was $22.5M in FY2026, relatively flat versus $22.3M in FY2025.
Exeter Select Automobile Receivables Trust 2026-1 8-K neutral materiality 7/10

21-05-2026

Exeter Select Automobile Receivables Trust 2026-1 filed an 8-K on May 21, 2026, announcing the issuance of eight classes of asset-backed notes totaling approximately $384.4 million, backed by sub-prime automobile loans. The offering includes Class A-1 (3.978%), A-2 (4.37%), A-3 (4.67%), B (4.99%), C (5.37%), D (6.10%), E (7.69%), and N (6.87%) notes, with the underwriters purchasing $333.3 million of the offered notes. The transaction involves multiple agreements executed around the May 27, 2026 closing date, including a Purchase Agreement, Sale and Servicing Agreement, and Indenture, with Deutsche Bank, Citigroup, and Mizuho as lead underwriters.

  • · The Underwriting Agreement was entered into on May 19, 2026, with Deutsche Bank Securities Inc., Citigroup Global Markets Inc., and Mizuho Securities USA LLC acting as representatives of the underwriters.
  • · The closing date for the transaction is on or about May 27, 2026.
  • · The Trust will also issue Asset Backed Certificates in the aggregate notional amount of $100,000.
  • · The assets of the Trust will include a certificate representing the entire beneficial interest in the Holding Trust, which initially holds a pool of retail installment sale contracts (sub-prime automobile loans).
  • · The offering is registered under SEC file number 333-268757.
  • · The CEO of EFCAR provided certifications required by Paragraph I.B.1(a) of Form SF-3, included in the Depositor Certification (Exhibit 36.1).
TPG Private Equity Opportunities, L.P. 8-K neutral materiality 6/10

21-05-2026

TPG Private Equity Opportunities, L.P. (T-POP) reported the sale of unregistered limited partnership units for aggregate consideration of $78.8 million on May 1, 2026, as part of its continuous private offering. The Fund also disclosed its Transactional Net Asset Value (NAV) as of April 30, 2026, totaling $1.486 billion, with per-unit values ranging from $31.37 (Class R-S) to $32.77 (Class F). The filing highlights ongoing capital raising and provides a detailed breakdown of NAV components, including a $1.493 billion investment in the Aggregator and various liabilities.

  • · The Fund sold 1,413,736 Class R-I units for $44,706,754, 768,583 Class R-S units for $24,113,000, and 305,197 Class F units for $10,000,000 on May 1, 2026.
  • · Out of the units sold, 905,224 Class R-I units and 305,197 Class F units were issued to Feeder TE in connection with its issuance of feeder class units to third-party investors.
  • · The T-POP Fund Complex (including the Fund) issued interests for aggregate consideration of approximately $84.9 million on May 1, 2026.
  • · As of April 30, 2026, Transactional NAV per unit was $31.62 (Class R-I), $31.37 (Class R-S), $31.55 (Class R-D), and $32.77 (Class F).
  • · Organizational and offering expenses advanced by the investment manager will be recognized as a reduction to Transactional NAV ratably over 60 months beginning in June 2026.
  • · Certain contingent tax liabilities may not be recognized as a reduction to Transactional NAV if the general partner expects they will not be realized upon divestment.
  • · The Fund is an emerging growth company as defined under SEC rules.
FUELCELL ENERGY INC 8-K positive materiality 5/10

21-05-2026

FuelCell Energy announced the appointment of John Livingston to its Board of Directors, effective May 19, 2026. Livingston brings over 25 years of experience in strategy, technology, industrial operations, and cybersecurity, including founding Verve Industrial Protection (acquired by Rockwell Automation) and a 20-year tenure at McKinsey & Co. The appointment strengthens the Board's expertise as the company focuses on resilient power solutions for data centers and AI infrastructure amid growing cyber threats.

  • · Livingston founded Verve Industrial Protection, which was acquired by Rockwell Automation.
  • · His cybersecurity expertise covers operational technology environments including substations, chillers, battery energy storage systems, on-site generation, building management systems, and control networks.
  • · FuelCell Energy's global fuel cell deployments approach one gigawatt.
AMKOR TECHNOLOGY, INC. 8-K neutral materiality 3/10

21-05-2026

Amkor Technology, Inc. filed an 8-K on May 21, 2026, announcing an Investor Day for institutional investors and financial analysts held on the same date at Convene 810 Seventh Avenue in New York City. The filing includes an investor presentation as Exhibit 99.1, furnished under Regulation FD, and does not contain any financial results or quantitative data.

  • · The Investor Day was held on May 21, 2026, at Convene 810 Seventh Avenue in New York City.
  • · The presentation is furnished as Exhibit 99.1 and is not deemed filed under the Exchange Act.
  • · The filing is under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits).
STEELE BANCORP INC 8-K neutral materiality 3/10

21-05-2026

Steele Bancorp, Inc. filed an 8-K on May 21, 2026, announcing a press release declaring a dividend. No specific dividend amount or financial figures were provided in the filing.

  • · The press release is titled 'Steele Bancorp, Inc. Declares Dividend' and is attached as Exhibit 99.1.
  • · The filing is dated May 21, 2026, and the press release was issued on the same date.
  • · No financial statements or other exhibits were included beyond the press release and cover page.
Federal Home Loan Bank of Chicago 8-K neutral materiality 6/10

21-05-2026

Federal Home Loan Bank of Chicago filed an 8-K disclosing the issuance of consolidated obligation bonds and discount notes on trade dates May 18-19, 2026, with total par value of $776 million across 11 tranches. The obligations are joint and several among the eleven Federal Home Loan Banks, backed solely by their financial resources and not guaranteed by the U.S. government. Coupon rates range from 3.800% to 6.000%, with maturities extending to 2056, and all bonds are callable with various call styles (American, Bermudan, European).

  • · All bonds are callable with Optional Principal Redemption; call styles include American, Bermudan, and European.
  • · The largest single issuance was $250M (two tranches: one maturing 11/20/2026 at 3.800%, one maturing 9/2/2027 at 4.120%).
  • · The longest maturity is 30 years (2056) with a 6.000% coupon.
  • · The shortest maturity is 6 months (11/20/2026) with a 3.800% coupon.
  • · Consolidated obligations are joint and several obligations of all eleven Federal Home Loan Banks, not guaranteed by the U.S. government.
  • · The filing does not include discount notes with maturity ≤1 year issued in ordinary course, nor does it reflect total outstanding obligations.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: S&P 500 Consumer Staples Sector SEC Filings

🇺🇸 More from United States

View all →